175 related articles for article (PubMed ID: 35326720)
1. Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c.
Wan Q; Zeng Z; Qi J; Zhao Y; Liu X; Chen Z; Zhou H; Zu Y
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326720
[TBL] [Abstract][Full Text] [Related]
2. Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells.
Chen Z; Zeng Z; Wan Q; Liu X; Qi J; Zu Y
Biomaterials; 2022 Jan; 280():121259. PubMed ID: 34801254
[TBL] [Abstract][Full Text] [Related]
3. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Identification of Aptamers against CD49c for the Detection, Capture, and Release of Cancer Cells.
Lv J; Li S; Zhen X; Li D; Zhang N; Liu X; Han J; Bing T; Shangguan D
ACS Appl Bio Mater; 2022 Jul; 5(7):3461-3468. PubMed ID: 35792891
[TBL] [Abstract][Full Text] [Related]
5. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers.
Liao YC; Cheng TC; Tu SH; Chang J; Guo P; Chen LC; Ho YS
Mol Ther Nucleic Acids; 2023 Sep; 33():351-366. PubMed ID: 37547295
[TBL] [Abstract][Full Text] [Related]
7. Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer.
Pleiko K; Haugas M; Parfejevs V; Pantelejevs T; Parisini E; Teesalu T; Riekstina U
Mol Ther Nucleic Acids; 2023 Sep; 33():871-884. PubMed ID: 37680989
[TBL] [Abstract][Full Text] [Related]
8. Triple Negative Breast Cancer Detection Using LC-MS/MS Lipidomic Profiling.
Eghlimi R; Shi X; Hrovat J; Xi B; Gu H
J Proteome Res; 2020 Jun; 19(6):2367-2378. PubMed ID: 32397718
[TBL] [Abstract][Full Text] [Related]
9. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.
Duan T; Xu Z; Sun F; Wang Y; Zhang J; Luo C; Wang M
Biomed Pharmacother; 2019 Sep; 117():109121. PubMed ID: 31252265
[TBL] [Abstract][Full Text] [Related]
10. Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer.
Zhou SM; Cheng L; Guo SJ; Wang Y; Czajkowsky DM; Gao H; Hu XF; Tao SC
Breast Cancer Res; 2015 Mar; 17(1):36. PubMed ID: 25848723
[TBL] [Abstract][Full Text] [Related]
11. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
[TBL] [Abstract][Full Text] [Related]
12.
Kasten BB; Oliver PG; Kim H; Fan J; Ferrone S; Zinn KR; Buchsbaum DJ
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561763
[TBL] [Abstract][Full Text] [Related]
13. Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles.
Ibarra LE; Camorani S; Agnello L; Pedone E; Pirone L; Chesta CA; Palacios RE; Fedele M; Cerchia L
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336001
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
Ashraf Y; Mansouri H; Laurent-Matha V; Alcaraz LB; Roger P; Guiu S; Derocq D; Robin G; Michaud HA; Delpech H; Jarlier M; Pugnière M; Robert B; Puel A; Martin L; Landomiel F; Bourquard T; Achour O; Fruitier-Arnaudin I; Pichard A; Deshayes E; Turtoi A; Poupon A; Simony-Lafontaine J; Boissière-Michot F; Pirot N; Bernex F; Jacot W; du Manoir S; Theillet C; Pouget JP; Navarro-Teulon I; Bonnefoy N; Pèlegrin A; Chardès T; Martineau P; Liaudet-Coopman E
J Immunother Cancer; 2019 Feb; 7(1):29. PubMed ID: 30717773
[TBL] [Abstract][Full Text] [Related]
15. Effect of an alkyl spacer on the morphology and internalization of MUC1 aptamer-naphthalimide amphiphiles for targeting and imaging triple negative breast cancer cells.
Kuang H; Schneiderman Z; Shabana AM; Russo GC; Guo J; Wirtz D; Kokkoli E
Bioeng Transl Med; 2021 Jan; 6(1):e10194. PubMed ID: 33532593
[TBL] [Abstract][Full Text] [Related]
16. RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE.
Suthe SR; Yao HP; Weng TH; Hu CY; Feng L; Wu ZG; Wang MH
Mol Cancer Ther; 2018 Dec; 17(12):2654-2664. PubMed ID: 30275241
[TBL] [Abstract][Full Text] [Related]
17. Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer.
Liu H; Bai L; Huang L; Ning N; Li L; Li Y; Dong X; Du Q; Xia M; Chen Y; Zhao L; Li Y; Meng Q; Wang J; Duan Y; Ming J; Yuan AQ; Yang XP
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599021
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.
Cabezón T; Gromova I; Gromov P; Serizawa R; Timmermans Wielenga V; Kroman N; Celis JE; Moreira JM
Mol Cell Proteomics; 2013 Feb; 12(2):381-94. PubMed ID: 23172894
[TBL] [Abstract][Full Text] [Related]
19. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.
Alcaraz LB; Mallavialle A; David T; Derocq D; Delolme F; Dieryckx C; Mollevi C; Boissière-Michot F; Simony-Lafontaine J; Du Manoir S; Huesgen PF; Overall CM; Tartare-Deckert S; Jacot W; Chardès T; Guiu S; Roger P; Reinheckel T; Moali C; Liaudet-Coopman E
Theranostics; 2021; 11(13):6173-6192. PubMed ID: 33995652
[No Abstract] [Full Text] [Related]
20. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
